Back to companies
ARS Pharmaceuticals, Inc.
SPRYUSNASDAQPharmaceuticals & HealthcareARS Pharmaceuticals, Inc.
Revenue
$84.3mn
YoY -5.5%
Operating income
-$179.4mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API